Challenges for nuclear medicine in the 1990s.
This article discusses the problems facing nuclear medicine in the coming decade and outlines the areas in which new developments or expansion can be expected. The questions considered include legislative requirements, the need to educate the public and the medical profession on the strengths of nuclear medicine, approaches to cost-benefit analysis, and development of new technologies and new radiopharmaceuticals. There is also an evaluation of expansion in nuclear medicine using both existing methodology and new methodologies.
Ell
P J
PJ
Institute of Nuclear Medicine, University College and Middlesex School of Medicine, London, UK.
D003362:Cost-Benefit Analysis; D006801:Humans; D009683:Nuclear Medicine / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends*; D011832:Radiation Injuries; D016499:Radioimmunotherapy; D012306:Risk; D006113:United Kingdom